North Tide Capital
Latest statistics and disclosures from North Tide Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SEM, MCK, Supervalu, Mylan Nv, GILD, and represent 61.76% of North Tide Capital's stock portfolio.
- Added to shares of these 9 stocks: MCK (+$54M), Supervalu (+$44M), Express Scripts Holding (+$22M), CVS (+$20M), Invacare Corporation (+$16M), Mylan Nv (+$11M), THC (+$8.8M), ENDPQ (+$8.6M), PACB (+$5.3M).
- Started 5 new stock positions in Express Scripts Holding, CVS, Invacare Corporation, Supervalu, PACB.
- Reduced shares in these 7 stocks: Tivity Health (-$71M), GILD (-$41M), Supervalu (-$33M), , SEM (-$9.6M), , Vivus (-$6.1M).
- Sold out of its positions in BioScrip, Impax Laboratories, Supervalu, Vivus.
- North Tide Capital was a net buyer of stock by $4.7M.
- North Tide Capital has $469M in assets under management (AUM), dropping by 4.33%.
- Central Index Key (CIK): 0001557543
Tip: Access up to 7 years of quarterly data
Positions held by North Tide Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for North Tide Capital
North Tide Capital holds 13 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Select Medical Holdings Corporation (SEM) | 18.4 | $86M | -10% | 4.5M | 19.20 |
|
| McKesson Corporation (MCK) | 16.4 | $77M | +233% | 500k | 153.61 |
|
| Supervalu | 9.3 | $44M | NEW | 2.0M | 21.75 |
|
| Mylan Nv | 9.0 | $42M | +35% | 1.4M | 31.37 |
|
| Gilead Sciences (GILD) | 8.6 | $41M | -50% | 500k | 81.02 |
|
| Endo International (ENDPQ) | 7.3 | $34M | +33% | 4.0M | 8.56 |
|
| Tivity Health | 6.5 | $31M | -70% | 750k | 40.80 |
|
| Perrigo Company (PRGO) | 5.4 | $25M | 300k | 84.65 |
|
|
| Tenet Healthcare Corporation (THC) | 5.4 | $25M | +53% | 1.5M | 16.43 |
|
| Express Scripts Holding | 4.7 | $22M | NEW | 350k | 63.32 |
|
| CVS Caremark Corporation (CVS) | 4.3 | $20M | NEW | 250k | 81.32 |
|
| Invacare Corporation | 3.4 | $16M | NEW | 1.0M | 15.75 |
|
| Pacific Biosciences of California (PACB) | 1.1 | $5.3M | NEW | 1.0M | 5.25 |
|
Past Filings by North Tide Capital
SEC 13F filings are viewable for North Tide Capital going back to 2012
- North Tide Capital 2017 Q3 filed Nov. 14, 2017
- North Tide Capital 2017 Q2 filed Aug. 14, 2017
- North Tide Capital 2017 Q1 filed May 15, 2017
- North Tide Capital 2016 Q4 filed Feb. 14, 2017
- North Tide Capital 2016 Q3 filed Nov. 14, 2016
- North Tide Capital 2016 Q2 filed Aug. 15, 2016
- North Tide Capital 2016 Q1 filed May 16, 2016
- North Tide Capital 2015 Q4 filed Feb. 16, 2016
- North Tide Capital 2015 Q3 filed Nov. 16, 2015
- North Tide Capital 2015 Q2 filed Aug. 14, 2015
- North Tide Capital 2015 Q1 filed May 15, 2015
- North Tide Capital 2014 Q4 filed Feb. 13, 2015
- North Tide Capital 2014 Q3 filed Nov. 14, 2014
- North Tide Capital 2014 Q2 filed Aug. 14, 2014
- North Tide Capital 2014 Q1 filed May 15, 2014
- North Tide Capital 2013 Q4 filed Feb. 14, 2014